LifeStance Health Group, Inc. LFST
$12.51
-$0.10-0.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 7.90% | 5.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.90% | 5.57% | |||
| Cost of Revenue | 5.52% | 4.55% | |||
| Gross Profit | 12.59% | 7.63% | |||
| SG&A Expenses | 6.97% | 5.81% | |||
| Depreciation & Amortization | 6.99% | -0.86% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.95% | 4.68% | |||
| Operating Income | 41.10% | 23.47% | |||
| Income Before Tax | 38.95% | 29.97% | |||
| Income Tax Expenses | -30.31% | 56.07% | |||
| Earnings from Continuing Operations | 65.78% | 22.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 65.78% | 22.07% | |||
| EBIT | 41.10% | 23.47% | |||
| EBITDA | 28.37% | 13.11% | |||
| EPS Basic | 67.39% | 22.26% | |||
| Normalized Basic EPS | 42.86% | 33.74% | |||
| EPS Diluted | 63.04% | 24.75% | |||
| Normalized Diluted EPS | 43.96% | 34.58% | |||
| Average Basic Shares Outstanding | -0.97% | 0.07% | |||
| Average Diluted Shares Outstanding | -1.97% | -0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||